PLZF Expression during Colorectal Cancer Development and in Normal Colorectal Mucosa according to Body Size, as Marker of Colorectal Cancer Risk

Figure 1

CD2, CD56, and PLZF fluorescence levels along colorectal carcinogenesis. Fluorescence levels of CD2 (a), CD56 (b), and PLZF (c) immunostaining in normal colorectal mucosa (NM), aberrant crypt foci (ACF), and colorectal carcinoma (CRC), expressed by immunofluorescence intensity score (IFIS). ^#𝑃<0.05 versus NM; *𝑃<0.05 versus CRC.

(a)

(b)

(c)